Daisuke Yasuda

Takatsuki, 5691094, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

KMN003 activates Nrf2 via disruption of the Keap1-Nrf2 interaction and p38-dependent transcriptional regulation.

KMN003 activates Nrf2 via disruption of the Keap1-Nrf2 interaction and p38-dependent transcriptional regulation.

Journal: Cellular signalling

Published: July 14, 2025

Development of Keap1-Nrf2 Protein-Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene-2-acetamide Scaffold, and its Anti-Inflammatory Effects.

Development of Keap1-Nrf2 Protein-Protein Interaction Inhibitor Activating Intracellular Nrf2 Based on the Naphthalene-2-acetamide Scaffold, and its Anti-Inflammatory Effects.

Journal: ChemMedChem

Published: June 09, 2025

Development of Fluorescent Estrogen Receptor Ligands with pH Sensor Functionality.

Development of Fluorescent Estrogen Receptor Ligands with pH Sensor Functionality.

Journal: Chemical & pharmaceutical bulletin

Published: April 29, 2025

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Journal: Journal of neurochemistry

Published: December 19, 2024

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease.

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease.

Journal: Bioorganic & medicinal chemistry letters

Published: October 01, 2022

Deficiency of Nardilysin in the Liver Reduces Serum Cholesterol Levels.

Deficiency of Nardilysin in the Liver Reduces Serum Cholesterol Levels.

Journal: Biological & pharmaceutical bulletin

Published: March 01, 2021

Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH).

Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH).

Journal: Biological & pharmaceutical bulletin

Published: April 03, 2020

Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line.

Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line.

Journal: Free radical research

Published: February 21, 2020

Ropinirole, a New ALS Drug Candidate Developed Using iPSCs.

Ropinirole, a New ALS Drug Candidate Developed Using iPSCs.

Journal: Trends in pharmacological sciences

Published: September 24, 2019

Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.

Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine.

Journal: Drug metabolism and pharmacokinetics

Published: September 19, 2019

Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study.

Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study.

Journal: Biological & pharmaceutical bulletin

Published: December 04, 2018

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.

Journal: Bioorganic & medicinal chemistry letters

Published: August 22, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026